Acquiring Company
Warburg Pincus Access Fund L.P
Acquired Company
Pharma Intelligence
New YorkFinancial ServicesSoftwareSales And MarketingFinanceBiotechnologyMedia And EntertainmentData And AnalyticsScience And EngineeringSales And MarketingDescription
Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment. The investors plan to extend the company's leading position in the pharmaceutical data and analytics market, investing in the creation of innovative products for its customers. Informa will retain 15% ownership in the company.
Quick answer
Warburg Pincus Access Fund L.P is acquiring Pharma Intelligence, announced February 10, 2022. Warburg Pincus Access Fund L.P is based in New York, New York, United States.
- How much did Warburg Pincus Access Fund L.P pay for Pharma Intelligence?
- The deal value was not disclosed.
- What does Warburg Pincus Access Fund L.P do?
- Warburg Pincus Access Fund, L.P. is an investment fund that focuses on providing access to private equity investments.
- Where are Warburg Pincus Access Fund L.P and Pharma Intelligence based?
- Warburg Pincus Access Fund L.P is based in New York, New York, United States.
- Who are the decision-makers at Warburg Pincus Access Fund L.P?
- Fundz holds 2 contacts at Warburg Pincus Access Fund L.P. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Financial Services and Sales And Marketing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Intellia Therapeutics Announces Acquisition Of Rewrite Therapeutics (February 3, 2022)
- Mntn Acquires Quickframe On Heels Of Ryan Reynolds’ Maximum Effort Deal (January 20, 2022)
- Global Omnichannel Survey Platform Leader Voxco Acquires Actify Data Labs, A True North Company (January 11, 2022)
- Voya Investment Management Completes Acquisition Of The Investment Advisory Business Of Tygh Capital Management (January 3, 2022)
- Amsive Completes Acquisition Of Genesis Direct (March 16, 2022)
- Beyond Limits Announces Acquisition Of Altec (March 2, 2022)
Who to call at Warburg Pincus Access Fund L.P, and when
When Warburg Pincus Access Fund L.P changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Warburg Pincus Access Fund L.P raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Warburg Pincus Access Fund L.P, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Warburg Pincus Access Fund L.P. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Warburg Pincus Access Fund L.P makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Pharma Intelligence?
Pharma Intelligence was acquired by Warburg Pincus Access Fund L.P, based in New York. The deal was reported on February 10, 2022. Warburg Pincus Access Fund, L.P. is an investment fund that focuses on providing access to private equity investments. Warburg Pincus Access Fund L.P is privately held and operates in Financial Services.
When did Warburg Pincus Access Fund L.P acquire Pharma Intelligence?
Warburg Pincus Access Fund L.P's acquisition of Pharma Intelligence was reported on February 10, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Pharma Intelligence do?
A leading operator in the $22bn global pharma and life sciences analytics markets, Pharma Intelligence delivers highly valued specialist intelligence and data in areas of Clinical Trials, Drug Development and Regulatory Compliance. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.